Invention Grant
- Patent Title: Piperazine compounds for the treatment of autoimmune disease
-
Application No.: US17262170Application Date: 2019-07-22
-
Publication No.: US11952363B2Publication Date: 2024-04-09
- Inventor: Fabian Dey , Zongxing Qiu , Wei Zhu , Ge Zou
- Applicant: Hoffmann-La Roche Inc.
- Applicant Address: US NJ Little Falls
- Assignee: Hoffmann-La Roche Inc.
- Current Assignee: Hoffmann-La Roche Inc.
- Current Assignee Address: US NJ Little Falls
- Agency: Genentech, Inc.
- Priority: WO TCN2018096661 2018.07.23
- International Application: PCT/EP2019/069609 2019.07.22
- International Announcement: WO2020/020800A 2020.01.30
- Date entered country: 2021-01-21
- Main IPC: C07D401/14
- IPC: C07D401/14 ; C07D471/04 ; C07D498/08
Abstract:
The present invention relates to compounds of formula (I), wherein R1 to R4 are as described herein, and their pharmaceutically acceptable salt, enantiomer or diastereomer thereof, and compositions including the compounds and methods of using the compounds.
Public/Granted literature
- US20210269423A1 PIPERAZINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE Public/Granted day:2021-09-02
Information query
